Bradac J - Search Results

1

HIV vaccine development: Lessons from the past, informing the future.

Bradac J, Dieffenbach CW. Bradac J, et al. IDrugs. 2009 Jul;12(7):435-9. IDrugs. 2009. PMID: 19579164 Review.

2

Current advances and challenges in HIV-1 vaccines.

Rodriguez-Chavez IR, Allen M, Hill EL, Sheets RL, Pensiero M, Bradac JA, D'Souza MP. Rodriguez-Chavez IR, et al. Among authors: bradac ja. Curr HIV/AIDS Rep. 2006 Feb;3(1):39-47. doi: 10.1007/s11904-006-0007-0. Curr HIV/AIDS Rep. 2006. PMID: 16522258 Review.

3

Neutralization of HIV-1.

Golding H, D'Souza MP, Bradac J, Mathieson B, Fast P. Golding H, et al. Among authors: bradac j. AIDS Res Hum Retroviruses. 1994 Jun;10(6):633-43. doi: 10.1089/aid.1994.10.633. AIDS Res Hum Retroviruses. 1994. PMID: 8074927

4

Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group.

D'Souza MP, Livnat D, Bradac JA, Bridges SH. D'Souza MP, et al. Among authors: bradac ja. J Infect Dis. 1997 May;175(5):1056-62. doi: 10.1086/516443. J Infect Dis. 1997. PMID: 9129066

5

Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007.

Girard MP, Bansal GP, Pedroza-Martins L, Dodet B, Mehra V, Schito M, Mathieson B, Delfraissy JF, Bradac J. Girard MP, et al. Among authors: bradac j. Vaccine. 2008 Jul 29;26(32):3969-77. doi: 10.1016/j.vaccine.2008.04.051. Epub 2008 May 8. Vaccine. 2008. PMID: 18513838 Free PMC article.

6

Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies.

D'Souza MP, Milman G, Bradac JA, McPhee D, Hanson CV, Hendry RM. D'Souza MP, et al. Among authors: bradac ja. AIDS. 1995 Aug;9(8):867-74. doi: 10.1097/00002030-199508000-00006. AIDS. 1995. PMID: 7576320

7

The HIV vaccine pipeline, from preclinical to phase III.

Schultz AM, Bradac JA. Schultz AM, et al. Among authors: bradac ja. AIDS. 2001;15 Suppl 5:S147-58. doi: 10.1097/00002030-200100005-00018. AIDS. 2001. PMID: 11816163 Review. No abstract available.

8

Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay.

Mascola JR, Louder MK, Surman SR, Vancott TC, Yu XF, Bradac J, Porter KR, Nelson KE, Girard M, McNeil JG, McCutchan FE, Birx DL, Burke DS. Mascola JR, et al. Among authors: bradac j. AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1319-28. doi: 10.1089/aid.1996.12.1319. AIDS Res Hum Retroviruses. 1996. PMID: 8891111

9

Summary of the Antigenic Variation Working Group.

Bradac J, Ho D. Bradac J, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1419-21. doi: 10.1089/aid.1992.8.1419. AIDS Res Hum Retroviruses. 1992. PMID: 1466971 No abstract available.

10

Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization.

Gao F, Yue L, Craig S, Thornton CL, Robertson DL, McCutchan FE, Bradac JA, Sharp PM, Hahn BH. Gao F, et al. Among authors: bradac ja. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1359-68. doi: 10.1089/aid.1994.10.1359. AIDS Res Hum Retroviruses. 1994. PMID: 7888189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters